SCHEMBL23360716

SCHEMBL23360716

NC(=O)Oc1c([N+](=O)[O-])ccc(N2CCCCC2)c1F

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.56
MAPT P10636 6/20 0.56
GAA P10253 3/20 0.53
L3MBTL1 Q9Y468 3/20 0.53
PKM P14618 2/20 0.53
POLB P06746 3/20 0.50
SMN1; SMN2 Q16637 4/20 0.47
MAPK1 P28482 4/20 0.47
HTT P42858 2/20 0.47
TDP1 Q9NUW8 1/20 0.47
CYP1A2 P05177 3/20 0.47
CYP2C19 P33261 3/20 0.47
CYP2C9 P11712 1/20 0.47
NPSR1 Q6W5P4 2/20 0.46
LMNA P02545 2/20 0.46
CTSB P07858 1/20 0.46
AR P10275 1/20 0.46
MEN1 O00255 1/20 0.45
USP2 O75604 1/20 0.45
TNNI3 P19429 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23360731 0.82 KDM4E (0.46) ALDH1A1MAPTGAAL3MBTL1PKM
SCHEMBL21031716 0.77 ALDH1A1 (0.67) ALDH1A1MAPTGAAL3MBTL1PKM
SCHEMBL939398 0.76 ALDH1A1 (0.68) ALDH1A1MAPTGAAL3MBTL1PKM
SCHEMBL25796770 0.74 ALDH1A1 (0.67) ALDH1A1MAPTGAAL3MBTL1PKM
SCHEMBL8103840 0.74 ALDH1A1 (0.70) ALDH1A1MAPTGAAL3MBTL1PKM
SCHEMBL8484094 0.74 ALDH1A1 (0.62) ALDH1A1MAPTGAAL3MBTL1PKM
SCHEMBL23360737 0.73 ALDH1A1 (0.58) ALDH1A1MAPTGAAL3MBTL1PKM
SCHEMBL3315189 0.72 MAPT (0.54) ALDH1A1MAPTGAAMAPK1LMNA
SCHEMBL29241408 0.71 ATM (0.40) ALDH1A1MAPTGAASMN1; SMN2HTT
SCHEMBL28897833 0.71 ALDH1A1 (0.51) ALDH1A1MAPTGAAL3MBTL1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691970-B2 Pyrazolopyridinone compounds JANSSEN PHARMACEUTICA NV (BE) 2023-07-04 US disclosed
EP-3713941-B1 PYRAZOLOPYRIDINONE COMPOUNDS JANSSEN PHARMACEUTICA NV (BE) 2022-06-22 EP disclosed
US-20210147411-A1 PYRAZOLOPYRIDINONE COMPOUNDS JANSSEN PHARMACEUTICA NV (BE) 2021-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210147411-A1 PYRAZOLOPYRIDINONE COMPOUNDS FGFR1, FGFR3, FGFR2 ALDH1A1 1418/4885MAPT 1516/4885GAA 1537/4885
US-11691970-B2 Pyrazolopyridinone compounds FGFR1, FGFR3, FGFR2 ALDH1A1 1418/4885MAPT 1516/4885GAA 1537/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.